仙乐健康
(300791)
| 流通市值：56.38亿 | | | 总市值：68.27亿 |
| 流通股本：1.50亿 | | | 总股本：1.82亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 951,504,195.36 | 3,582,022,297.17 | 2,502,922,802.68 | 1,544,847,837.25 |
| 营业收入 | 951,504,195.36 | 3,582,022,297.17 | 2,502,922,802.68 | 1,544,847,837.25 |
| 二、营业总成本 | 879,047,243.89 | 3,311,572,714.55 | 2,305,834,727.33 | 1,444,525,424.24 |
| 营业成本 | 660,171,232.59 | 2,497,911,669.03 | 1,748,274,556.78 | 1,089,856,315.5 |
| 税金及附加 | 6,943,324.96 | 22,414,702.98 | 15,957,547.11 | 9,451,541.02 |
| 销售费用 | 73,086,246.12 | 277,608,277.49 | 185,346,698.1 | 114,345,161.14 |
| 管理费用 | 91,971,266.66 | 350,830,160.17 | 245,462,851.88 | 165,414,017.62 |
| 研发费用 | 30,794,385.11 | 110,494,627.39 | 75,471,289.32 | 46,496,020.83 |
| 财务费用 | 16,080,788.45 | 52,313,277.49 | 35,321,784.14 | 18,962,368.13 |
| 其中:利息费用 | 17,797,747.5 | 61,856,078.25 | 50,001,367.73 | 32,023,686.22 |
| 其中:利息收入 | 1,398,682.44 | 7,016,136.93 | 8,762,653.19 | 3,261,766.03 |
| 加:公允价值变动收益 | 2,741,910.99 | -57,671,784.35 | -12,816,293.78 | -6,978,164.34 |
| 加:投资收益 | -4,869,171.98 | 2,219,562.72 | 3,981,765.21 | 2,688,543.93 |
| 资产处置收益 | 131,961.11 | 34,010.25 | 22,900.05 | 47,109.17 |
| 资产减值损失(新) | -1,362,568.92 | 405,379.29 | -828,294.24 | -2,242,170.86 |
| 信用减值损失(新) | 69,468.21 | -5,177,105.91 | -451,130.78 | 2,421,536.2 |
| 其他收益 | 3,745,697.18 | 71,765,029.85 | 10,562,398.72 | 6,679,847.43 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 72,914,248.06 | 282,024,674.47 | 197,559,420.53 | 102,939,114.54 |
| 加:营业外收入 | 1,153,300.77 | 1,364,680.09 | 1,285,430.95 | 536,648.63 |
| 减:营业外支出 | 4,743,215.32 | 10,132,526.7 | 2,111,441.04 | 727,865.85 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 69,324,333.51 | 273,256,827.86 | 196,733,410.44 | 102,747,897.32 |
| 减:所得税费用 | 15,453,196.98 | 32,969,032.59 | 37,032,497.02 | 22,803,586.87 |
| 六、净利润 | 53,871,136.53 | 240,287,795.27 | 159,700,913.42 | 79,944,310.45 |
| 持续经营净利润 | 53,871,136.53 | 240,287,795.27 | 159,700,913.42 | 79,944,310.45 |
| 归属于母公司股东的净利润 | 63,029,722.56 | 281,038,527.77 | 185,147,820.63 | 101,185,645.67 |
| 少数股东损益 | -9,158,586.03 | -40,750,732.5 | -25,446,907.21 | -21,241,335.22 |
| (一)基本每股收益 | 0.35 | 1.56 | 1.03 | 0.56 |
| (二)稀释每股收益 | 0.35 | 1.56 | 1.03 | 0.56 |
| 八、其他综合收益 | -26,692,941.41 | 19,667,233.37 | 73,625,275.16 | 76,347,618.77 |
| 归属于母公司股东的其他综合收益 | -21,136,400.31 | 14,237,409.72 | 70,485,395.12 | 74,560,549.63 |
| 九、综合收益总额 | 27,178,195.12 | 259,955,028.64 | 233,326,188.58 | 156,291,929.22 |
| 归属于母公司股东的综合收益总额 | 41,893,322.25 | 295,275,937.49 | 255,633,215.75 | 175,746,195.3 |
| 归属于少数股东的综合收益总额 | -14,715,127.13 | -35,320,908.85 | -22,307,027.17 | -19,454,266.08 |
| 公告日期 | 2024-04-22 | 2024-04-22 | 2023-10-26 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |